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Background: This study aimed to identify the toxin production
and toxin geneproﬁles ofClostridiumdifﬁcile species through inves-
tigation of C.difﬁcile antigen glutamate dehydrogenase, toxinA+B
and toxin genes in the stool samples of cases of hospital acquired
enteritis.
Methods & Materials: Eighty-three patients between 2012-
2013 were included in the study. Data of the patients were reached
through screening the computerized operating system of the hos-
pital and patient ﬁles.
Results: Risk factors such as presence of malignancy, chronic
diseases, chemotherapy, radiotherapy and immunosuppression
were present in the majority of the patients (Table). C.difﬁcile anti-
genwas found to be positive in 5 patients usingmembrane enzyme
immunoassay. ToxinA+B positivity was not found in any patients
with membrane EIA. Toxin-B gene positivity was found in 3 out
of 5 patients with C.difﬁcile antigen positivity with real-time poly-
merase chain reaction method. Binary toxin gene positivity and
single base deletion in nucleotide 117 of the tcdC gene were found
in no patients. In conclusion, C.difﬁcile infection was identiﬁed in
3 patients and C.difﬁcile colonization with non-toxigenic species
was determined in 2 patients. The incidence of hospital originated
CDI was calculated to be 0,10/10,000 patient admission days and
0,06/10,000 patient presentation.
Table Epidemiological data of the patients
Epidemiological data Number (%)
Clinic Internal 74 (%90,2)
Surgical 5 (%6,1)
ICU* 3 (%3,7)
Antibiotic usage 1 antibiotic 23 (%40,4)
2 antibiotic 24 (%42,1)
≥3 antibiotic 10 (%17,5)
Chemotherapy No 46 (%56,1)
Yes 36 (%43,9)
Radiotherapy No 80 (%97,6)
Yes 2 (%2,4)
Chronic disease No 51 (%62,2)
Yes 31 (%37,8)
Malignancy No 43 (%52,4)
Yes 39 (%47,6)
* Intensive Care Unite
Conclusion: CDI is seen in varying rates in different hospitals
and countries. In addition, the test methods and kits used con-
ditions of transport, storage, examination of the samples and the
epidemiological characteristics of the patients might inﬂuence the
CDI rates. We believe that the antibiotic usage policies and infec-
tion control precautions that are in practice in our hospital for
a long time are closely related with the low rates of CDI’s seen
in this study. GDH screening with EIA method in patients with
probable infectious enteritis and veriﬁcation by PCR in patients
with GDH positivity is considered as a quick, effective and reliable
method.
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Background: The problem of nosocomial infections caused by
P.aeruginosa is very urgent. Especially at production of metallo-
-lactamases by P. aeruginosa strains, which are the cause of
inefﬁciency of antibiotic treatment, including therapy by carbapen-
ems. Aim was to study of the dynamics of detecting of P.aeruginosa
MBL-producing strains in the Kazakhstan for 2009-2013.
Methods & Materials: The material was obtained during mul-
ticenter study on monitoring of the stability of nosocomial P.
aeruginosa, isolated in hospitals of Central Kazakhstan. The design:
multicenter prospective microbiological study of many years. It
was determined the sensitivity to antibiotics of 900 nosocomial
P. aeruginosa, isolated in the period January 2009-September
2013 in hospitals of Central Kazakhstan. The isolates were iden-
tiﬁed by time-of-ﬂight mass-spectrometry MALDI-TOF (Bruker
Daltoniks). The interpretation of antibiotic susceptibility was per-
formed according to CLSI 2007/2012. MBL production had been
identiﬁed phenotypically by double discs method with EDTA. The
detection of main resistance genes with carbapenemase activity
was performed by PCR in real time.
Results: The proportion of P. aeruginosa MBL-producing
strains in 2009 was 3,94% (n=254, 95% CI 1,55-6,33%), in
2010–12,99% (n=254, 95% CI 8,86-17,13%), in 2011–3,45% (n=87,
95% CI–0,39-7,28%), in 2012–16,13% (n=217, 95% CI 11,24-21,02%),
in 2013–9,09% (n=88, 95% CI 3,08-15,10%). It was revealed the sig-
niﬁcant increase of the proportion of P. aeruginosa MBL-producing
strains in 2010 and 2012 in comparison with the other years (Chi-
square value is from 19,676 to 41,841; p<0,0001). All the isolates
produced carbapenemases of blaVIM2 molecular class. According
to MLVA analysis all the isolates belong to the same clonal com-
plex.MLST-typing showed that all the strains belong to st235 clonal
group.
Conclusion: The study of the dynamics of detecting of P.
aeruginosa MBL-producing strains in Kazakhstan in 2009-2013
showed the circulating of MBL-producers of blaVIM2 molecular
class, which according to MLVA-analysis relate to the same clonal
complex. According to the results ofMLST-typing the strains belong
to st235 clonal group. In 2010 and 2012 it was registered the sig-
niﬁcant increase in the proportion of P. aeruginosaMBL-producers.
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